Literature DB >> 8554420

The role of tumor necrosis factor and nitric oxide in the acute cardiovascular response to endotoxin.

T J Fahey1, T Yoshioka, G T Shires, G A Fantini.   

Abstract

OBJECTIVE: This study was designed to examine the differential effects of tumor necrosis factor (TNF) and nitric oxide on the acute cardiovascular changes that occur in response to endotoxemia. SUMMARY BACKGROUND DATA: Recent studies have suggested that some, if not all, of the cardiovascular effects of TNF are mediated through release of nitric oxide. However, the mechanisms through which TNF and nitric oxide induce hypotension and shock in vivo in response to systemic endotoxemia remain poorly characterized, despite current interest in the use of nitric oxide antagonists to ameliorate septic shock.
METHODS: A reproducible model of endotoxemia was established in adult Sprague-Dawley rats. The acute cardiovascular changes that occur after bolus infusion of endotoxin was then determined in rats treated with either TNF antibody, N-methyl arginine, or both.
RESULTS: Inhibition of either TNF or nitric oxide restores mean arterial blood pressure to normal after endotoxemia (p < 0.05). However, nitric oxide exerts its effects principally on the peripheral vasculature, whereas TNF appears to act on the myocardium. A combination of TNF antiserum pretreatment and N-methyl arginine administration is necessary to return mean arterial blood pressure to normal 60 minutes after endotoxin infusion.
CONCLUSION: Tumor necrosis factor and nitric oxide mediate the acute cardiovascular effects of endotoxemia through distinct mechanisms. Nitric oxide is released as a result of both TNF-dependent and TNF-independent mechanisms, whereas the cardiovascular effects of TNF are only partially mediated through nitric oxide.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8554420      PMCID: PMC1235064          DOI: 10.1097/00000658-199601000-00009

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  21 in total

1.  Load-insensitive assessment of myocardial performance after tumor necrosis factor-alpha in dogs.

Authors:  F D Pagani; L S Baker; M A Knox; H Cheng; M P Fink; M S Visner
Journal:  Surgery       Date:  1992-06       Impact factor: 3.982

2.  Cytokine production in a model of wound healing: the appearance of MIP-1, MIP-2, cachectin/TNF and IL-1.

Authors:  T J Fahey; B Sherry; K J Tracey; S van Deventer; W G Jones; J P Minei; S Morgello; G T Shires; A Cerami
Journal:  Cytokine       Date:  1990-03       Impact factor: 3.861

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

5.  Tumor necrosis factor and cardiac function.

Authors:  J E DeMeules; F A Pigula; M Mueller; S J Raymond; R L Gamelli
Journal:  J Trauma       Date:  1992-06

6.  Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart.

Authors:  T Yokoyama; L Vaca; R D Rossen; W Durante; P Hazarika; D L Mann
Journal:  J Clin Invest       Date:  1993-11       Impact factor: 14.808

7.  Ibuprofen in canine endotoxin shock.

Authors:  E R Jacobs; M E Soulsby; R C Bone; F J Wilson; F C Hiller
Journal:  J Clin Invest       Date:  1982-09       Impact factor: 14.808

8.  Protective and pathological roles of nitric oxide in endotoxin shock.

Authors:  C E Wright; D D Rees; S Moncada
Journal:  Cardiovasc Res       Date:  1992-01       Impact factor: 10.787

9.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Authors:  B A Beutler; I W Milsark; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog.

Authors:  K J Tracey; S F Lowry; T J Fahey; J D Albert; Y Fong; D Hesse; B Beutler; K R Manogue; S Calvano; H Wei
Journal:  Surg Gynecol Obstet       Date:  1987-05
View more
  7 in total

1.  Tumor necrosis factor (TNF) and nitric oxide (NO) mediate the acute cardiovascular effects of endotoxemia.

Authors:  M Odeh
Journal:  Ann Surg       Date:  1997-03       Impact factor: 12.969

2.  Temporal expression of pro-inflammatory cytokines and inducible nitric oxide synthase in experimental acute Chagasic cardiomyopathy.

Authors:  B Chandrasekar; P C Melby; D A Troyer; J T Colston; G L Freeman
Journal:  Am J Pathol       Date:  1998-04       Impact factor: 4.307

3.  Increased nitric oxide activity in a rat model of acute pancreatitis.

Authors:  R A Al-Mufti; R C Williamson; R T Mathie
Journal:  Gut       Date:  1998-10       Impact factor: 23.059

4.  Changes in the response of neutrophils to endotoxin priming following major abdominal surgery.

Authors:  Yoshihiro Moriwaki; Mitsugi Sugiyama; Yukihiro Ozawa; Yasuhisa Mochizuki; Chikara Kunisaki; Noriyuki Kamiya; Yasunobu Yamazaki; Takashi Suda
Journal:  World J Surg       Date:  2002-02-25       Impact factor: 3.352

5.  Persistent systemic inflammatory response after stent insertion in patients with malignant bile duct obstruction.

Authors:  A B Ballinger; J A Woolley; M Ahmed; H Mulcahy; E M Alstead; J Landon; M L Clark; M J Farthing
Journal:  Gut       Date:  1998-04       Impact factor: 23.059

6.  Depletion of phagocytes in the reticuloendothelial system causes increased inflammation and mortality in rabbits with Pseudomonas aeruginosa pneumonia.

Authors:  Kiyoyasu Kurahashi; Teiji Sawa; Maria Ota; Osamu Kajikawa; Keelung Hong; Thomas R Martin; Jeanine P Wiener-Kronish
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-11-21       Impact factor: 5.464

Review 7.  Toll-like receptor and its roles in myocardial ischemic/reperfusion injury.

Authors:  Yu Fang; Jianguo Hu
Journal:  Med Sci Monit       Date:  2011-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.